Publicaciones
Inmunoterapia activa en el tratamiento de neoplasias hematológicas
...leer más
Bases moleculares de la inmunología del cáncer
...leer más
Pardoll DM. Cancer immunology.
In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors. Abeloff's Clinical Oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008
Waldmann TA. Effective cancer therapy through immunomodulation. Annual Review of Medicine 2006; 57:65–81
...leer más
ioud M. An overview of the immune system and technical advances in tumor antigen discovery and validation.
SMethods in Molecular Biology 2007; 360:277–318.
...leer más
Inmunoterapia del cáncer: Importancia de controlar la inmunosupresión:
...leer más
Inmunoterapia activa en cáncer de próstata
Revisión con atención especial a las células dendríticas
...leer más
Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention.
Nature Reviews Cancer 2006; 6(3):204–216
...leer más
Frazer IH, Lowy DR, Schiller JT. Prevention of cancer through immunization
Prospects and challenges for the 21st century. European Journal of Immunology 2007; 37(Suppl 1):S148–S155.
...leer más
Frazer IH, Lowy DR, Schiller JT. Prevention of cancer through immunization
Prospects and challenges for the 21st century. European Journal of Immunology 2007; 37(Suppl 1):S148–S155.
...leer más
Uso de diferentes combinaciones de inmunoterapia en pacientes
...leer más
Avances en inmunoterapia celular contra el melanoma maligno
...leer más
Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer
Clinical Science 2006; 110(5):525–541
...leer más
Parkin DM. The global health burden of infection-associated cancers in the year 2002
International Journal of Cancer 2006; 118(12):3030–3044
...leer más
Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines
Journal of Clinical Investigation 2006; 116(5):1167–1173
...leer más
Centers for Disease Control and Prevention
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States:
recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents.
Morbidity and Mortality Weekly Report 2005; 54(No. RR–16):1–31.
...leer más
>Mueller NE. Cancers caused by infections: unequal burdens
Cancer Epidemiology, Biomarkers & Prevention 2003; 12(3):237s.
...leer más
International Agency for Research on Cancer (2011)
Agents Classified by the IARC Monographs , Volumes 1–100. Retrieved November 15, 2011
...leer más
Rivoltini L, Canese P, Huber V, et al
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opinion on Biological Therapy 2005; 5(4):463–476.
...leer más
Rosenberg SA, Yang JC, Restifo NP
Cancer immunotherapy: moving beyond current vaccines. Nature Medicine 2004; 10(9):909–915
...leer más
Renkvist N, Castelli C, Robbins PF, Parmiani G
A listing of human tumor antigens recognized by T cells. Cancer Immunology and Immunotherapy 2001; 50(1):3–15
...leer más
Parmiani G, Russo V, Marrari A, et al
Universal and stemness-related tumor antigens: potential use in cancer immunotherapy. Clinical Cancer Research 2007; 13(19):5675–5679
...leer más
Kantoff PW, Higano CS, Shore ND, et al
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New England Journal of Medicine 2010; 363(5):411–422
...leer más
Parmiani G, De Filippo A, Novellino L, Castelli C
Unique human tumor antigens: immunobiology and use in clinical trials. The Journal of Immunology 2007; 178(4):1975–1979
...leer más
Finn OJ. Cancer immunology
The New England Journal of Medicine 2008; 358(25):2704–2715
...leer más
Curigliano G, Spitaleri G, Dettori M, et al. Vaccine immunotherapy in breast cancer treatment
Promising, but still early. Expert Review of Anticancer Therapy 2007; 7(9):1225–1241
...leer más
Chiarella P, Massi E, De Robertis M, Signori E, Fazio VM
Adjuvants in vaccines and for immunisation: current trends. Expert Opinion on Biological Therapy 2007; 7(10):1551–1562
...leer más
Herr HW, Morales A. History of Bacillus Calmette-Guérin and bladder cancer
An immunotherapy success story. The Journal of Urology 2008; 179(1):53–56
...leer más
Emens LA. Chemotherapy and tumor immunity
An unexpected collaboration. Frontiers in Bioscience 2008; 13:249–257
...leer más
Schlom J, Arlen PM, Gulley JL
Cancer vaccines: moving beyond current paradigms. Clinical Cancer Research 2007; 13(13):3776–3782
...leer más
Ng LG, Mrass P, Kinjyo I, Reiner SL, Weninger W. Two-photon imaging of effector T-cell behavior
Lessons from a tumor model. Immunological Reviews 2008; 221:147–162
...leer más
Garnett CT, Greiner JW, Tsang KY, et al
TRICOM vector based cancer vaccines. Current Pharmaceutical Design 2006; 12(3):351–361
...leer más
Zou W. Regulatory T cells, tumour immunity and immunotherapy
Nature Reviews Immunology 2006; 6(4):295–307
...leer más
Vacunas terapéuticas en cáncer. Ensayos clínicos actuales
Dra. María del C. Arango Prado1 y Lic. Alicia González Sánchez2
...leer más
Natural Killer Cell Activation through the Issels Immunotherapy Protocol
by Walter H. Kim and Christian N. Issels, 2009
...leer más